DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 37 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,426 | -34.8% | 89,700 | +9.2% | 0.00% | – |
| Q2 2023 | $354,931 | +155.4% | 82,160 | -9.5% | 0.00% | – |
| Q1 2023 | $138,962 | -5.5% | 90,825 | -2.4% | 0.00% | – |
| Q4 2022 | $147,057 | +31.3% | 93,068 | +3.1% | 0.00% | – |
| Q3 2022 | $112,000 | -45.6% | 90,254 | -11.3% | 0.00% | – |
| Q2 2022 | $206,000 | -17.6% | 101,704 | +1.8% | 0.00% | – |
| Q1 2022 | $250,000 | -33.9% | 99,942 | -1.3% | 0.00% | – |
| Q4 2021 | $378,000 | +10.2% | 101,283 | +18.4% | 0.00% | – |
| Q3 2021 | $343,000 | -9.5% | 85,570 | +0.4% | 0.00% | – |
| Q2 2021 | $379,000 | -51.3% | 85,195 | +0.2% | 0.00% | – |
| Q1 2021 | $778,000 | -36.6% | 85,026 | -29.7% | 0.00% | – |
| Q4 2020 | $1,227,000 | +147.9% | 120,989 | +3.6% | 0.00% | – |
| Q3 2020 | $495,000 | -25.5% | 116,767 | +21.8% | 0.00% | – |
| Q2 2020 | $664,000 | +1797.1% | 95,871 | +669.1% | 0.00% | – |
| Q1 2020 | $35,000 | – | 12,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $369,293 | 0.45% |
| COOPERMAN LEON G | 812,508 | $1,283,844 | 0.08% |
| CATALYST FINANCIAL PARTNERS LLC | 14,475 | $22,872 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $1,580 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $292 | 0.00% |
| STATE STREET CORP | 133,258 | $210,548 | 0.00% |
| MORGAN STANLEY | 55,201 | $87,223 | 0.00% |
| BlackRock Inc. | 69,937 | $110,508 | 0.00% |
| Bank of New York Mellon Corp | 36,062 | $56,982 | 0.00% |
| Citadel Advisors | 1,600 | $2,528 | 0.00% |